Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
269
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+388K
-
Total reported value, excl. options
-
$4.26B
-
Value change
-
+$85M
-
Put/Call ratio
-
0.46
-
Number of buys
-
107
-
Number of sells
-
-152
-
Price
-
$222.22
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2017
304 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q3 2017.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 269 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (1.69M shares), BlackRock Inc. (1.69M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.58M shares), ACADIAN ASSET MANAGEMENT LLC (890K shares), TimesSquare Capital Management, LLC (665K shares), AMERICAN CENTURY COMPANIES INC (566K shares), STATE STREET CORP (541K shares), WELLS FARGO & COMPANY/MN (536K shares), ARIEL INVESTMENTS, LLC (524K shares), and BANK OF AMERICA CORP /DE/ (524K shares).
This table shows the top 269 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.